Published in HealthyRaho: Who Is Suitable for GFC Therapy in Knee Osteoarthritis?

Dr. Mayur Rabhadiya’s evidence-based article on patient selection for Growth Factor Concentrate (GFC) therapy in knee osteoarthritis has been published by HealthyRaho. The article focuses on where GFC may reasonably fit, where expectations should be limited, and why the diagnosis and stage of arthritis matter more than the treatment label.

What the article explains

The publication argues against treating every patient with knee osteoarthritis as a candidate for an injection. A clinically reasonable discussion starts with the diagnosis, symptom pattern, examination, functional limitation, alignment, imaging and response to appropriate non-surgical care.

For selected patients with early-to-moderate symptomatic knee osteoarthritis, a blood-derived injection may be considered as a symptom-modifying option. The intended goal is improvement in pain and function, not a promise of cartilage regeneration or reversal of established osteoarthritis.

Why patient selection matters

The article also explains when injections become less compelling. Severe joint-space loss, substantial deformity, instability, fixed stiffness or major functional limitation can indicate a mechanical problem that an injection is unlikely to correct. Repeated injections should not become a way to postpone a necessary discussion about definitive treatment when advanced arthritis is substantially affecting daily life.

The evidence base is described cautiously. PRP has a larger clinical literature than GFC, while GFC-specific evidence remains more limited. The article therefore avoids claiming that GFC is universally superior to PRP or that either treatment is appropriate for every stage of knee osteoarthritis.

Read the HealthyRaho publication

Read the full HealthyRaho article: Who Is Actually Suitable for GFC Therapy in Knee Osteoarthritis? A Stage-Based Patient Selection Guide

Related clinical resources

For a broader evidence-based overview of treatment selection, see Dr Mayur Rabhadiya’s guide to GFC therapy for knee arthritis.

Patients who are unsure whether their symptoms are still suitable for conservative treatment can also review the knee arthritis treatment pathway in Mumbai.

The complete record of peer-reviewed research, external medical authorship and verified media coverage is available on the Dr Mayur Rabhadiya Publications, Research & Media Coverage page.

The practical message is deliberately conservative: an injection should be considered only when it has a reasonable evidence-based objective for that individual patient. It should not be promoted as a guaranteed alternative to knee replacement or as proof that damaged cartilage will regrow.